Related Experiment Video
Updated: May 10, 2026

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
Preclinical models of antipsychotic drug action
José L Moreno1, Javier González-Maeso
1Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA.
Abstract:
One of the main obstacles faced by translational neuroscience is the development of animal models of psychiatric disorders. Behavioural pharmacology studies indicate that psychedelic drugs, such as lysergic acid diethylamide (LSD) and dissociative drugs, such as phencyclidine (PCP), induce in healthy human volunteers psychotic and cognitive symptoms that resemble some of those observed in schizophrenia patients. Serotonin 5-HT2A and metabotropic glutamate 2 receptors have been involved in the mechanism of action of psychedelic and dissociative drugs. Here we review recent advances using LSD-like and PCP-like drugs in rodent models that implicate these receptors in the neurobiology of schizophrenia and its treatment.
More Related Videos
Related Concept Videos
Antipsychotic Drugs: Typical and Atypical Agents
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Preclinical Development: Overview
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Pharmacodynamic Models: Overview

